The group draws on the complementary expertise of a full service firm including EU and competition, product liability, regulatory, intellectual property, dispute resolution, equity capital markets, M&A and corporate finance. This cross practice structure leverages the expertise of individual team members from different specialisations (including members of the
Science Unit) and enables us to provide our clients with fully integrated solutions to the increasingly challenging regulatory and commercial issues affecting the global life sciences industry.